HYPERTONIA ÉS NEPHROLOGIA - eLitMed.hu

2002; 6 (S3): 53–65. NeoRecormon ® Quality of Life 2001 65
pulzusnyomás magas, illetve a diastolés érték csökkent, a
vérnyomás beállítása óvatosságot igényel. Ezen betegeknél
a jelenleg optimálisnak tartható célértékek: 150–160
Hgmm systolés, illetve 85–90 Hgmm diastolés vérnyomás.
IRODALOM
1. MacMahon S. Rodgers A. The effects of antihypertensive
treatment on vascular disease: reappraisal of the evidence in
1994. J Vasc Med biol 1993; 4:265-271.
2. MacMahon S. Peto R, Cutler J, et al. Blood pressure, stroke and
coronary heart disease. Part 1. Prolonged differences in blood
pressure: prospective observational studies corrected for the
regression dilution bias. Lancet 1990; 335:765-774.
3. Eastern Stroke and coronary Heart Disease Collaborative
Research group. Blood pressure, chlolesterol and stroke in
Eastern Asia. Lancet 1998; 352:1801-1807.
4. Fletcher A, Beever DG, Bulpitt CJ et al. The relationship
between a low treated blood pressure and IHD mortality: a report
from DHSS Hypertension Care Hypertension Care Computing
Project (DHCCP) J Hum Hypertens 1988; 2:11-15.
5. Klag MJ, Whelton PK, Randall Bl et al. Blood pressure and
end-stage renal disease. N Engl J Med 1996; 334: 13-18.
6. Klag MJ, Whelton PK, Randall BI et al. End-stage renal disease
in African-American and white men: 16-year MRFIT findigs.
JAMA 1997; 277:1293-1298.
7. Valderrabano F, Gomez-Capdera F, Jones EHP. Hypertension as
a cause of end-stage renal disease: lessons from international
registries. Kidney Int 1998, 54 Suppl 68: S60-66
8. Bergström J, Alvestrand A, Bucht H, Gutlerrez A. Progression of
chronic renal failure in man is related with more frequent clinical
follow-up and better blood pressure control. Clin Nephrol 1986;
25:1-6.
9. Joint National Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure.The Sixth Report of the
Joint National Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure. Arch Intern Med 1997;
157:2413-2446.
10. 1999 World Health Organization-International Society of
Hypertension Guidelines for the Management of Hypertension. J
Hypertens 1999; 17:151-183.
11. Charra B, Calemard E, Ruffet M et al. Survival as an index of
adequacy of dialysis. Kidney Int 1992; 41:1286-1293.
12. Zager PG, Nikolic J, Brown RH et al: ’U’ curve association of
blood pressure and mortality in hemodialysis patients, Kidney Int
1998; 54: 561-569.
13. Port FK, Hulbert-Shearon TE, Wolfe RA, et al, Predialysis blood
pressure and mortality risk in a national sample of maintenance
hemodialysis patients. Am J Kidney Dis 1999; 33: 505-517
14. Iseki K, Miyasato F, Tokuyama K et al, Low diastolic blood
pressure, hypoalbuminemia, and risk of death in a cohort of
chronic hemodialysis patients. Kidney Int 1997; 51:1212-1217.
15. Blacher J, Guérin AP, Pannier B et al, Impact of aortic stiffness
on survival in end-stage renal disease. Circulation 1999;
99:2434-2439.
16. London GM, Guérin AP, Marchais SJ. Pressure-overload
cardiomyopathy in end-stage renal disease. Curr Opin Nephrol
Hypertens 1999; 8:179-186.
17. Mailloux LU, Haley WE, Hypertension in the ESRD patient:
Pathophysiology, therapy, outcomes and future directions. Am J
Kidney Dis 1998; 32:705-716.
18. London GM, Controversy on optimal blood pressure on haemodialysis:
lower is not always better. Nephrol Dial Transplant
2001; 16:475-478.
19. O’rourke M. Mechanical principles in arterial disease. Hypertension
1995; 26:2-9.